Head and Neck Cancer Trial, Recruiting NCT06659146 Sponsor: King's College London Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06659146
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a cancer that cannot be cured or removed by surgery, and who have at least one tumour near the surface of the skin or in a lymph node that is suitable for treatment with a specific heat-based device (the hydrosun® TWH1500)
  • People who are already receiving a standard palliative radiotherapy treatment that matches the specific doses and schedules set out in the trial plan
  • People who are 18 years of age or older
  • People who are generally well enough to carry out daily activities with little to no limitation (this is measured using a standard medical scale — confirm with trial site)
  • People who are able to understand the trial and give their own informed consent to participate

Who may not be able to join:

  • People who do not have a tumour near the surface of the skin or a lymph node that is suitable for treatment with the hydrosun® TWH1500 device
  • People whose radiotherapy treatment does not match one of the specific dose and schedule options set out in the trial plan
  • People who have a known psychiatric condition or substance use disorder that may make it difficult to follow the requirements of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anthony Kong, Clinical reader and honorary NHS consultant in clinical oncology

Phone: 44+2078486004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 October 2024
Est. completion
1 March 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Real-world implementation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov